Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study.
The Lancet Regional Health - Europe（2023）
摘要
Amgen.
更多查看译文
关键词
Atherosclerotic cardiovascular disease, LDL-C, Lipid-lowering, ESC/EAS guidelines, Cardiovascular risk
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要